UBS Group Lowers Ryan Specialty (NYSE:RYAN) Price Target to $59.00

Ryan Specialty (NYSE:RYAN) had its target price cut by investment analysts at UBS Group from $65.00 to $59.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target suggests a potential upside of 69.17% from the stock’s current price.

RYAN has been the subject of a number of other reports. Barclays decreased their price objective on Ryan Specialty from $45.00 to $41.00 and set an “overweight” rating for the company in a research report on Wednesday. Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $55.00 to $49.00 and set an “outperform” rating for the company in a research report on Tuesday. The Goldman Sachs Group decreased their price objective on Ryan Specialty from $57.00 to $49.00 and set a “buy” rating for the company in a research report on Wednesday. Mizuho decreased their price objective on Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating for the company in a research report on Friday, February 27th. Finally, JPMorgan Chase & Co. decreased their price objective on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating for the company in a research report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, Ryan Specialty currently has a consensus rating of “Hold” and an average price target of $50.44.

Ryan Specialty Stock Down 0.1%

Shares of NYSE RYAN opened at $34.88 on Wednesday. The stock has a market cap of $9.21 billion, a PE ratio of 83.04, a price-to-earnings-growth ratio of 0.92 and a beta of 0.71. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a 52-week low of $31.50 and a 52-week high of $75.26. The business has a 50-day moving average price of $38.48 and a 200 day moving average price of $48.54.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The firm had revenue of $751.21 million during the quarter, compared to analyst estimates of $777.43 million. During the same period last year, the company earned $0.45 earnings per share. The firm’s revenue for the quarter was up 13.2% compared to the same quarter last year. Equities research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current year.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of Ryan Specialty stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This represents a 6.33% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 52.03% of the stock is owned by corporate insiders.

Institutional Trading of Ryan Specialty

Hedge funds have recently modified their holdings of the business. Los Angeles Capital Management LLC acquired a new stake in shares of Ryan Specialty in the 4th quarter valued at approximately $25,000. Advisory Services Network LLC acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $28,000. SBI Securities Co. Ltd. lifted its holdings in shares of Ryan Specialty by 6,322.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company’s stock valued at $30,000 after buying an additional 569 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Ryan Specialty by 65.4% in the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company’s stock valued at $34,000 after buying an additional 242 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Ryan Specialty by 83.7% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock valued at $35,000 after buying an additional 273 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: UBS cut its target from $65 to $59 but kept a “buy” rating, leaving a large implied upside and signaling continued conviction in the company’s medium‑term outlook. UBS lowers PT TickerReport
• Positive Sentiment: Goldman Sachs lowered its PT from $57 to $49 but maintained a “buy” rating, preserving a sizable upside and supporting buyer interest at current levels. Goldman lowers PT
• Positive Sentiment: Morgan Stanley reduced its target to $50 (reported via American Banking News) but retained a view that implies meaningful upside versus the current price. Morgan Stanley lowers PT
• Positive Sentiment: Wells Fargo cut its PT to $42 but stayed “overweight,” signaling that analysts still see outperformance potential despite the downward revision. Wells Fargo lowers PT TickerReport
• Positive Sentiment: Barclays trimmed its target to $41 but kept an “overweight” stance, leaving modest upside that supports the stock relative to peers. Barclays lowers PT
• Neutral Sentiment: Cantor Fitzgerald lowered its target to $40 and moved to a “neutral” rating, reflecting a more cautious stance that is unlikely to drive strong buying or selling by itself. Cantor Fitzgerald note
• Neutral Sentiment: Keefe, Bruyette & Woods reduced its price target (reported to $49) — another downward revision that adds to the consensus reset but did not alone change the narrative. Keefe Bruyette lowers PT
• Neutral Sentiment: Coverage roundup/analyst commentary pieces (e.g., Globe and Mail summary) circulated, consolidating the mixed analyst views without introducing new catalyst. Globe and Mail roundup
• Negative Sentiment: JPMorgan cut its target to $43 and moved to “underweight,” representing a clear negative signal from a major house and contributing to downside pressure on the shares. JPMorgan lowers PT

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.